NOAC/DOAC Labeled Uses/Approved Indications Flashcards
What are the FDA-approved indications for Dabigatran?
-Postoperative prophylaxis (hip)
-Non-valvular atrial fibrillation
-DVT/PE treatment
What are the FDA-approved indications for Rivaroxaban?
-Postoperative prophylaxis
-Non-valvular atrial fibrillation
-DVT/PE treatment
-Secondary prevention of recurrent DVT/PE
-VTE prophylaxis
What are the FDA-approved indications for Apixaban?
-Postoperative prophylaxis
-Non-valvular atrial fibrillation
-DVT/PE treatment
-Secondary prevention of recurrent DVT/PE
What are the FDA-approved indications for Edoxaban?
-Non-valvular atrial fibrillation
-DVT/PE treatment
How do you define the labeled use of postoperative prophylaxis?
-Postoperative thromboprophylaxis of DVT which may lead to PE in patients undergoing KNEE OR HIP replacement surgery
How do you define the labeled use of non-valvular atrial fibrillation?
-Prevention of stroke and systemic embolism in patients with NON-VALVULAR atrial fibrillation
How do you define the labeled use of DVT/PE treatment?
-Treatment of DVT/PE (straightforward)
How do you define the labeled use of VTE prophylaxis?
-Prophylaxis of VTE in adults HOSPITALIZED FOR AN ACUTE MEDICAL ILLNESS who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for VTE
How do you define the labeled use of secondary prevention of recurrent DVT and/or PE?
-Reduction in the risk of recurrence of DVT and PE FOLLOWING INITIAL 6 MONTHS OF TREATMENT for DVT and/or PE
What are the NOACs/DOACs
-Dabigatran etexilate (Pradaxa)
-Rivaroxaban (Xarelto)
-Apixaban (Eliquis)
-Edoxaban (Savaysa)
-Betrixaban (Bevyxxa)
Which NOACs/DOACs are BID dosing for atrial fibrillation?
-Dabigatran
-Apixaban
Which NOACs/DOACs are once-daily dosing for atrial fibrillation?
-Rivaroxaban
-Edoxaban
How does apixaban differ from the other NOACs in renal adjustment?
Apixaban is the only medication that is adjusted based on SCr instead of CrCl
Which two criteria must be met in order to warrant dose adjustment for apixaban when treating non-valvular atrial fibrillation?
-Age of 80 or older
-body weight of 60kg or less
-SCr of 1.5 or more
When is it not recommended to use edoxaban?
When the CrCl is above 95